Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds

British Journal of Cancer

Volumn 74, Issue 12, 1996, Pages 1949-1954

  Versantvoort, C H M ^a   Rhodes, T ^a   Twentyman, P R ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Flavones; Genistein; Multidrug resistance; Multidrug resistance protein

Indexed keywords

DAIDZEIN; DAUNORUBICIN; FLAVONOID; GENISTEIN; GENISTIN; QUERCETIN; RHODAMINE 123;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; HUMAN; HUMAN CELL; LUNG CANCER; MEMBRANE POTENTIAL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030469817     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.658     Document Type: Article

References (19)

1. BARRAND MA, RHODES T, CENTER MS AND TWENTYMAN PR. (1993). Chemosensitisation and drug accumulation effects of cyclosporin A, PSC833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Eur. J. Cancer, 29A, 408-415.
2. BARRAND MA, HEPPEL-PARTON AC, WRIGHT KA, RABBITS PH AND TWENTYMAN PR. (1994). A 190k protein overexpressed in non-P-glycoprotein containing MDR cells and its relation to the MRP gene. J. Natl Cancer Intl., 86, 110-117.
3. CHAUDHARY PM AND RONINSON IB. (1991). Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66, 85-94.
4. COLE SPC, BHARDAWAJ G, GERLACH JH, MACKIE JE, GRANT CE, ALMQUIST KC, STEWART AJ, KURZ EU, DUNCAN AMV AND DEELEY RG. (1992). Overexpression of a novel transporter gene in a multidrug resistant human lung cancer cell line. Science, 258, 1650-1654.
5. CRITCHFIELD JW, WFLSH CJ, PHANG JM AND YEH GC. (1994). Modulation of adriamycin accumulation and efflux by flavonoids in HTC-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem. Pharmacol., 48, 1437-1445.
6. GOTTESMAN MM AND PASTAN I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62, 385-427.
7. GRANT CE, VALDIMARSSON G, HIPFNER E, ALMQUIST KC, COLE SPC AND DEELEY RG. (1994). Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54, 337-361.
8. HERMANN K. (1976). Flavonols and flavones in food plants: a review. J. Food. Technol., 11, 433-448.
9. JEDLITSCHKY G, LEIER I, BUCHHOLZ U, CENTER MS AND KEPPLER D. (1994). ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res., 54, 4833-4836.
10. LUTZKY J, ASTOR MB, TAUB RN, BAKER MA, BHALLA K, GERVASONI Jr, JE, ROSADO M, STEWART V, KRISHNA S AND HINDENBURG AA. (1989). Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Cancer Res., 49, 4120-4125.
11. MÜLLER M, MEIJER C, ZAMAN GJR, BORST P, SCHEPER RJ, MULDER NH DE VRIES EGE AND JANSEN PLM. (1994). Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl Acad. Sci. USA, 91, 13033-13037.
12. PHANG JM, POORE CM, LOPACZYNSKA J AND YEH GC. (1993). Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug resistant breast cancer cells. Cancer Res., 53, 5977-5981.
13. TWENTYMAN PR, FOX NE, WRIGHT KA AND BLEEHEN N. (1986). Derivation and preliminary characterisation of Adriamycin resistant lines of human lune cancer cells. Br. J. Cancer, 53, 529-537.
14. TWENTYMAN PR, RHODES T AND RAYNER S. (1994). A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Eur. J. Cancer, 30A, 1360-1369.
15. SCHUURHUIS GJ, BROXTERMAN HJ, OSSEKOPPHELE GJ, BAAK JPA, EEKMAN CA, KUIPER CM, FELLER N, VAN HEIJNINGEN THM, KLUMPER E, PIETERS R, LANKELMA J AND PINEDO HM. (1995). Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR-1 and MRP together with 1-β-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia. Clin. Cancer Res., 1, 81-93.
16. VERSANTVOORT CHM, SCHUURHUIS GJ, PINEDO HM, EEKMAN CA, KUIPER CM, LANKELMA J AND BROXTERMAN HJ. (1993). Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br. J. Cancer, 68, 939-946.
17. VERSANTVOORT CHM, BROXTERMAN HJ, LANKELMA J, FELLER N AND PINEDO HM. (1994). Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem. Pharmacol., 48, 1129-1136.
18. VERSANTVOORT CHM, BROXTERMAN HJ, BAGRIJ T, SCHEPER RJ AND TWENTYMAN PR. (1995). Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br. J. Cancer, 72, 82-89.
19. ZAMAN GJR, FLENS MJ, VAN LEUSDEN MR, DE HAAS M, MÜLDER HS, LANKELMA J, PINEDO HM, SCHEPER RJ, BROXTERMAN HJ AND BORST P. (1994). The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl Acad. Sci. USA, 91, 8822-8826.